BridgeMD
New treatment option for Cognitive Decline
Official title MASCoD - Multidimensional Assessment of Subjective Cognitive Decline
ClinicalTrials.gov ID: NCT05815329
What this study is testing
- What it's testing
- Subjective cognitive decline-SCD is a subclinical cognitive impairment subjectively experienced without being detectable from a diagnostic and neuropsychological perspective. It can negatively impact on patient's frailty and quality of life and it may be prodromal to severe cognitive impairment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- reported subjective cognitive decline without any other cognitive or neurological issue,
- Italian education,
- adult (\> 55 years old),
- understanding of research aims,
- signed informed consent,
You likely can't join if
- serious clinical conditions (e.g. severe cardiac and respiratory problems, neoplasia)
- prior diagnosis of psychiatric disorders according to DSM-5,
- prior diagnosis of cognitive decline,
- relevant visuo-perceptive or hearing deficits,
- illiteracy or relapse in illiteracy,
- refusal to partake in the research.
See the full eligibility criteria
- reported subjective cognitive decline without any other cognitive or neurological issue,
- Italian education,
- adult (\> 55 years old),
- understanding of research aims,
- signed informed consent,
- participation on a voluntary and non-payied bases.
- serious clinical conditions (e.g. severe cardiac and respiratory problems, neoplasia)
- prior diagnosis of psychiatric disorders according to DSM-5,
- prior diagnosis of cognitive decline,
- relevant visuo-perceptive or hearing deficits,
- illiteracy or relapse in illiteracy,
- refusal to partake in the research.
The study team makes the final eligibility decision.
Where it's taking place
- Montescano, Pavia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montescano, Pavia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.